Products

Kyros

AI-native

Run teams, not one agent at a time.

kyros.team Source★ 1Software Development / AI Coding Assistants & Editors

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Free
No monthly subscription pricing
Creators
Behruz
@behruzra· 13 followers
Launched
6mo ago
2026-05-13 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
X accounts@behruzra
  • Launched on Product HuntLaunch

    Run AI coding teams from your terminal

    May 13 · 6mo agoLaunch page

Open Source & Agent Ecosystem

GitHub · MCP / Skill
Last commit 2026-05-11
GitHub Stars
★ 1
Forks
—
License
See repository
Primary language
—

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered 2026-04-27

No search keyword data for this website yet.

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-05-13

Key pages

Weekly snapshots
Home
kyros.team/ Snapshot 2026-11-06

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does Kyros get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is Kyros and what platforms does it support?
Kyros is catalogued under AI Coding Assistants & Editors: Run teams, not one agent at a time.. Supported platforms: CLI / SDK.
Is Kyros open source?
Kyros has a public repository (https://github.com/bitooz/kyros-cli) with its source repository published, recording 1 GitHub stars.Source

Related products in this category

Software Development / AI Coding Assistants & Editors

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.